Uncategorized
Pharma-backed petition calls on FDA to reform release of drug rejection letters
The FDA for the first time is facing pharma-backed criticism of its new practice of publicly releasing partially redacted drug rejection letters.
The law firm Covington & Burling, on behalf of an unnamed pharmaceutical company …